From QOL to QALYs: Comparing nononcologic outcomes in prostate cancer survivors across treatments

The ability to measure and make useful data on nononcologic outcomes evolved substantially over the past 20 years. Current work suggests that individual preference assessment for nononcologic outcomes is a promising means of matching patients with appropriate treatment.